Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease

Efficacy and Safety of Systematic Therapy and Bronchoscopic Interventional Treatment for Pulmonary Mucormycosis

NCT06495905 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

Clinical Trial of Pulmonary Cryptococcosis in China

NCT02503449 ·Status: UNKNOWN

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

NCT01982071 ·Status: TERMINATED ·Phase: PHASE4

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

NCT00002159 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD

NCT05116059 ·Status: UNKNOWN

Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)

NCT06969703 ·Status: NOT_YET_RECRUITING

CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients

NCT02100761 ·Status: UNKNOWN

PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.

NCT03121235 ·Status: COMPLETED

Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis

NCT04225195 ·Status: UNKNOWN ·Phase: PHASE2

A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections

NCT00288197 ·Status: COMPLETED ·Phase: PHASE4

Retrospective Analysis of the Epidemiological Change and Determinants of Prognosis of Talaromycosisof Human Immunodeficiency Virus Negative Host in Guangxi

NCT03819348 ·Status: UNKNOWN

Itraconazole Therapy In Bronchiectasis With Airway Mold

NCT07283497 ·Status: RECRUITING ·Phase: PHASE4

A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus

NCT05707832 ·Status: COMPLETED ·Phase: PHASE3

Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological Diseases

NCT07135778 ·Status: RECRUITING

Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method

NCT02676570 ·Status: UNKNOWN

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

NCT02646774 ·Status: TERMINATED ·Phase: PHASE4

A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

NCT06194201 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

NCT04738955 ·Status: UNKNOWN ·Phase: PHASE4

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

NCT00003031 ·Status: COMPLETED ·Phase: PHASE3

Azole-echinocandin Combination Therapy for Invasive Aspergillosis

NCT04876716 ·Status: TERMINATED ·Phase: PHASE3

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

NCT00076869 ·Status: COMPLETED ·Phase: PHASE2

Amphotericin B for Non-HIV Cryptococcal Meningitis Patients

NCT06178627 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)

NCT00230243 ·Status: COMPLETED

Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease

NCT01499433 ·Status: UNKNOWN ·Phase: PHASE4

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

NCT00412893 ·Status: COMPLETED ·Phase: PHASE3